Clinical Trial Update: A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer [Phase 2]

View source ↗

Summary

Pfizer conducted a multicenter Phase 2 trial of CI-1040 in patients with advanced colorectal cancer, breast cancer, non-small cell lung cancer, and pancreatic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• CI-1040 (CI-1040)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms, Breast Neoplasms | Phase 2 | Status: COMPLETED